Signaling pathways
-
BA4457 ConvallatoxinSummary: Convallatoxin is a cardiac glycoside isolated from RegeletRadde. - BA4458 25-Hydroxytachysterol3Summary: 25-Hydroxytachysterol3 is the metabolite.
- BA4459 BAY-5094Summary: BAY-5094 is an inverse agonist.
- BA4460 FTX-6746Summary: FTX-6746 is an orally active inhibitor.
- BA4461 MA-0204Summary: MA-0204 is a potent, highly selective, orally active peroxisome proliferator-activated receptor δ modulator at 0.4 nM, 7.9 nM and 10 nM for human, mouse and rat, respectively.
- BA4462 FK614Summary: FK614 is an orally active non-thiazolidinedione (TZD) type selective modulator.
- BA4463 GSK376501ASummary: GSK376501A is a selective peroxisome proliferator-activated receptor gamma modulator.
- BA4464 RG-12525Summary: RG-12525 is a specific, competitive, orally available antagonist.
- BA4465 EdaglitazoneSummary: Edaglitazone is a potent, selective and orally active agonist.
- BA4466 NaveglitazarSummary: Naveglitazar (LY519818) is a peroxisome proliferator-activated receptor alpha-gamma dual.